Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 3.040
0.00 (0.00%)
At close: Dec 5, 2025
Clarity Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Cash & Equivalents | 47.68 | 47.9 | 31.21 | 55.34 | 8.44 | Upgrade
|
| Short-Term Investments | 36.43 | 88.6 | 33.8 | 37 | 10.5 | Upgrade
|
| Cash & Short-Term Investments | 84.12 | 136.51 | 65.01 | 92.34 | 18.94 | Upgrade
|
| Cash Growth | -38.38% | 109.96% | -29.59% | 387.54% | 202.28% | Upgrade
|
| Other Receivables | 10.1 | 12.63 | 10 | 6.66 | 3.37 | Upgrade
|
| Receivables | 10.1 | 12.63 | 10 | 6.66 | 3.37 | Upgrade
|
| Prepaid Expenses | 6.33 | 4.83 | 1.66 | 0.56 | 0.2 | Upgrade
|
| Other Current Assets | 0.06 | 0.09 | - | - | - | Upgrade
|
| Total Current Assets | 100.61 | 154.06 | 76.68 | 99.55 | 22.51 | Upgrade
|
| Property, Plant & Equipment | 0.55 | 0.55 | 0.21 | 0.26 | 0.09 | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 101.17 | 154.63 | 76.9 | 99.82 | 22.61 | Upgrade
|
| Accounts Payable | 3.21 | 2.08 | 2.85 | 2.85 | 0.23 | Upgrade
|
| Accrued Expenses | 4.36 | 2.7 | 1.84 | 4.16 | 1.18 | Upgrade
|
| Current Income Taxes Payable | - | 0.21 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.08 | Upgrade
|
| Other Current Liabilities | 2.82 | 3.09 | 2.85 | 0.49 | 0.76 | Upgrade
|
| Total Current Liabilities | 10.38 | 8.09 | 7.54 | 7.51 | 2.25 | Upgrade
|
| Other Long-Term Liabilities | 0.56 | 0.24 | 0.18 | 0.08 | 0.08 | Upgrade
|
| Total Liabilities | 10.94 | 8.33 | 7.72 | 7.59 | 2.34 | Upgrade
|
| Common Stock | 268.94 | 262.4 | 132.82 | 132.12 | 44.9 | Upgrade
|
| Retained Earnings | -176.99 | -112.7 | -70.37 | -45.8 | -28.85 | Upgrade
|
| Comprehensive Income & Other | -1.71 | -3.4 | 6.73 | 5.92 | 4.22 | Upgrade
|
| Shareholders' Equity | 90.23 | 146.3 | 69.18 | 92.24 | 20.28 | Upgrade
|
| Total Liabilities & Equity | 101.17 | 154.63 | 76.9 | 99.82 | 22.61 | Upgrade
|
| Net Cash (Debt) | 84.12 | 136.51 | 65.01 | 92.34 | 18.94 | Upgrade
|
| Net Cash Growth | -38.38% | 109.96% | -29.59% | 387.54% | 202.28% | Upgrade
|
| Net Cash Per Share | 0.26 | 0.50 | 0.25 | 0.37 | 0.11 | Upgrade
|
| Filing Date Shares Outstanding | 321.47 | 311.65 | 260.66 | 257.94 | 190.42 | Upgrade
|
| Total Common Shares Outstanding | 321.47 | 311.65 | 260.66 | 257.94 | 189.82 | Upgrade
|
| Working Capital | 90.23 | 145.97 | 69.14 | 92.04 | 20.26 | Upgrade
|
| Book Value Per Share | 0.28 | 0.47 | 0.27 | 0.36 | 0.11 | Upgrade
|
| Tangible Book Value | 90.23 | 146.3 | 69.18 | 92.24 | 20.28 | Upgrade
|
| Tangible Book Value Per Share | 0.28 | 0.47 | 0.27 | 0.36 | 0.11 | Upgrade
|
| Machinery | 1.1 | 0.93 | 0.44 | 0.39 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.